Merck

American pharmaceutical giant Merck seeks US authorisation for emergency use of anti-COVID pill

Merck has submitted the application for molnupiravir, which it said earlier this month was shown to reduce hospitalisations by 50 percent.

COVID-19 vaccine: Potential coronavirus vaccine candidate from China shows promise in animal tests

More than 100 potential COVID-19 vaccines are in various stages of development around the world.

Merck renamed as Procter & Gamble Health following P&G's global acquisition of consumer health business

Drug firm Merck Ltd on Tuesday said it has been renamed as Procter & Gamble Health Ltd following P&G's global acquisition of the consumer health business of Merck KGaA, Germany

Procter & Gamble India clocks 15% sales growth during July-December 2018; revamped strategy yields results

Procter & Gamble had reported a 10.64 percent increase in net profit at Rs 115.56 crore for the first quarter ended 30 September, 2018.

Reliance Jio tops Fortune's 'Change the World' list; ranked ahead of pharma giant Merck and Bank of America

Richest Indian Mukesh Ambani's telecom unit Reliance Jio has been ranked as the top company globally on Fortune's 'Change The World' list that ranked companies using the profit motive to help the planet and tackle social problems

P&G to acquire 51.8% stake in Merck India for Rs 1,290 cr; to make tender offer to minority shareholders

As part of the deal, P&G will buy a majority stake in the German company’s Indian consumer health business, Merck Ltd, and subsequently make a mandatory tender offer to minority shareholders.

Merck Selects Cognizant As Strategic Partner

Cognizant has announced a multi-year, multi-million dollar engagement with Merck & Co.

Sun Pharma to get $50 mn for developing skin disease drug for Spanish firm Almirall

According to Sun Pharma, Almirall will be able to lead European studies, and participate in larger Global clinical studies for psoriasis indication subject to the terms of the Sun Pharma - Merck agreements

Why the doubts over the Rotavac anti-diarrhoea vaccine may be overblown

Some doctors have raised questions about the clinical trials of the Rotavac vaccine. While their concerns are important, these can be addressed by observing the vaccine's side-effects over a larger sample of children in due course.

US drugmaker Merck grants free license for pediatric HIV drug

Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus.